BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37935729)

  • 41. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
    Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies.
    Bergamaschi C; Pagoni M; Rosati M; Angel M; Tzannou I; Vlachou M; Darmani I; Ullah A; Bear J; Devasundaram S; Burns R; Baltadakis I; Gigantes S; Dimopoulos MA; Pavlakis GN; Terpos E; Felber BK
    Front Immunol; 2022; 13():899972. PubMed ID: 35693807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
    Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Slow resolution of inflammation in severe adult dengue patients.
    Zhao L; Huang X; Hong W; Qiu S; Wang J; Yu L; Zeng Y; Tan X; Zhang F
    BMC Infect Dis; 2016 Jun; 16():291. PubMed ID: 27301555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune and coagulation profiles in 3 adults with multisystem inflammatory syndrome.
    Yap RXL; Leung BPL; Howe HS; Loh ME; Young BE; Fan BE; Lim XR
    Ann Acad Med Singap; 2023 Feb; 52(2):80-87. PubMed ID: 36880819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae.
    Bergantini L; d'Alessandro M; Gangi S; Bianchi F; Cameli P; Perea B; Meocci M; Fabbri G; Marrucci S; Ederbali M; Bargagli E
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.
    Tripathy AS; Vishwakarma S; Trimbake D; Gurav YK; Potdar VA; Mokashi ND; Patsute SD; Kaushal H; Choudhary ML; Tilekar BN; Sarje P; Dange VS; Abraham P
    Arch Virol; 2021 Dec; 166(12):3301-3310. PubMed ID: 34554303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokines in acute chikungunya.
    Venugopalan A; Ghorpade RP; Chopra A
    PLoS One; 2014; 9(10):e111305. PubMed ID: 25343623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.
    Willis R; Seif AM; McGwin G; Martinez-Martinez LA; González EB; Dang N; Papalardo E; Liu J; Vilá LM; Reveille JD; Alarcón GS; Pierangeli SS
    Lupus; 2012 Jul; 21(8):830-5. PubMed ID: 22343096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6.
    Ponthieux F; Dauby N; Maillart E; Fils JF; Smet J; Claus M; Besse-Hammer T; Bels D; Corazza F; Nagant C
    Viral Immunol; 2022; 35(1):60-70. PubMed ID: 35085462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity.
    MacCann R; Leon AAG; Gonzalez G; Carr MJ; Feeney ER; Yousif O; Cotter AG; de Barra E; Sadlier C; Doran P; Mallon PW
    Front Immunol; 2023; 14():1166574. PubMed ID: 37261339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
    Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
    Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Importance of screening severe COVID-19 patients for IFN-λ1, IL-6 and anti-S1 IgG levels.
    Kenanoğlu OB; Gül A; Can H; Karakavuk M; Erkunt Alak S; Korukluoğlu G; Altaş AB; Pullukçu H; Değirmenci Döşkaya A; Karakavuk T; Gül C; Çiçek C; Taşbakan MS; Çinkooğlu A; Ün C; Gürüz AY; Avcı M; Karasulu E; Tekin Ş; Döşkaya M; Işıkgöz Taşbakan M
    Cytokine; 2023 Nov; 171():156357. PubMed ID: 37690425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
    Adel Y; Sadeq Y
    Reumatologia; 2020; 58(4):221-230. PubMed ID: 32921829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Higher pro-inflammatory cytokines IL-6 and IFN-γ are associated with anti-SARS-CoV-2 spike protein-specific seroconversion in renal allograft recipients.
    Yadav B; Prasad N; Kushwaha RS; Patel MR; Bhadauria D; Kaul A
    Transpl Infect Dis; 2023 Oct; 25(5):e14133. PubMed ID: 37605477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between inflammatory cytokines/chemokines, clinical laboratory parameters, disease severity and in-hospital mortality in critical and mild COVID-19 patients without comorbidities or immune-mediated diseases.
    Hamza M; Alhujaily M; Alosaimi B; El Bakkouri K; AlDughaim MS; Alonazi M; Alanazi MA; Abbass B; Alshehri A; Al-Shouli ST; Alturaiki W; Awadalla M
    J Immunoassay Immunochem; 2023 Jan; 44(1):13-30. PubMed ID: 35915975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
    Karaba AH; Zhou W; Hsieh LL; Figueroa A; Massaccesi G; Rothman RE; Fenstermacher KZJ; Sauer L; Shaw-Saliba K; Blair PW; Robinson ML; Leung S; Wesson R; Alachkar N; El-Diwany R; Ji H; Cox AL
    Clin Infect Dis; 2022 Jan; 74(2):254-262. PubMed ID: 34013339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.